Abstract
Clotting factors play an important role in the pathophysiology of cardiovascular disease (CVD). In fact, plasma fibrinogen concentration is directly associated with the incidence of CVD [1], while a 1% decrease in factor VII (FVII) activity leads to a 2% reduction in the risk of death from coronary heart disease [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ernst E. Fibrinogen: An important risk factor for atherothrombotic diseases. Ann Med 1994;26:15–22.
Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986;ii:533–37.
Scarabin PY, Plu-Bureau G, Bara L, Bonithon-Kopp C, Guize L, Samama MM. Haemostatic variables and menopausal status. Influence of hormone replacement therapy. Thromb Haemost 1993;70:584–87.
Meade TW, Dyer S, Howarth DJ, Jamieson JD, Stirling Y. Antithrombin III and procoagulant activity: Sex differences and effects of the menopause. Br J Haematol 1990;74:77–81.
The writing group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199–208.
Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biological effects of transdermal estradiol. N Engl J Med 1986;314:1615–20.
Alkjaersig N, Fletcher AP, De Ziegler D, Steingold KA, Meldrum DR, Judd HL. Blood coagulation in postmenopausal women given estrogen treatment: Comparison of transdermal and oral administration. J Lab Clin Med 1988;111:224–28.
Boschetti C, Cortellaro M, Nencioni T, Bertolli V, Delia Volpe A, Zanussi C. Short-and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women. Thromb Res 1991;62:1–8.
Fox J, George AJ, Newton JR, et al. Effect of transdermal oestradiol on the haemostatic balance of menopausal women. Maturitas 1993;18:55–64.
Kroon U-B, Silfverstolpe G, Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 1994;71:420–23.
The writing group for the Estradiol Clotting Factors Study. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: A 1-year, double-blind, placebo-controlled study. Thrombosis and Haemostasis 1996;75:476–80.
Nabulsi AA, Folsom AR, White A, et al. for the Atherosclerosis Risk in Communities Study Investigators. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069–75.
Lobo AA, Pickard JH, Wild RA, Walsh B, Hirvonen E for the Menopause Study Group. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 1994;84:987–95.
Daly E, Vessey MP, Hawkins MH, et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977–80.
Jick H, Derby LE, Myers MW, et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996;348:981–83.
Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996;348:983–87.
Meade TW, Cooper J, Miller GJ, Howarth DJ, Stirling Y. Antithrombin III and arterial disease. Lancet 1991;338:850–51.
Cortellaro M. Antithrombin III and arterial disease. Lancet 1991;338:1525–26.
Conlan MG, Folsom AR, Finch A, et al. Antithrombin III: Associations with age, race, sex and cardiovascular disease risk factors. Thromb Haemost 1994;72:551–56.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Crosignani, P.G., Boschetti, C., Cortellaro, M., Meschia, M. (1997). Menopause, HRT, and Hemostasis. In: Paoletti, R., Crosignani, P.G., Kenemans, P., Samsioe, G., Soma, M.R., Jackson, A.S. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5560-1_15
Download citation
DOI: https://doi.org/10.1007/978-94-011-5560-1_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6343-2
Online ISBN: 978-94-011-5560-1
eBook Packages: Springer Book Archive